Merand Pharmaceuticals, Inc. — Form D

Merand Pharmaceuticals, Inc. of CHARLOTTESVILLE, VA, a company, filed a Form D exempt-offering notice with the SEC on 2019-07-23. The offering totals $1.3M, of which $1.1M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2019-07-23
• Form: D
• Accession: 0001780981-19-000001
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $1.3M
• Amount sold: $1.1M
• Remaining: $115K
• Investors: 11
• Date of first sale: 2019-07-12
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-344857

Issuer

• Name: Merand Pharmaceuticals, Inc.
• CIK: 0001780981
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2018
• Address: 1878 CATLIN ROAD, CHARLOTTESVILLE, VA, 22901
• Phone: 1-800-829-4933

Officers, directors & promoters (7)

More

• CIK 1780981 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search